Clinical trials are vital to improving the prevention, screening, diagnosis and treatment of melanoma and skin cancer.
Melanoma and Skin Cancer Trials Limited (MASC Trials) is Australian and New Zealand’s collaborative trials group specialising in investigator-initiated melanoma and skin cancer research, supported by the Australian government via Cancer Australia.
Our vision is to improve the lives of melanoma and skin cancer patients, and of their families, through delivery of high-quality trials that seek to improve outcomes and reduce the burden of these diseases in our community. Our collaborative approach sits at the heart of everything we do and drives outcomes that have the potential to improve disease prevention and patient care on a global scale.
Working with multidisciplinary medical and research professionals around the globe, MASC Trials conducts clinical trials and related biological research to improve treatments for melanoma and non-melanoma skin cancers. We also work closely with consumer advocates to ensure their experience and unique perspectives are considered in clinical trial prioritization and development.
To learn about our research, including the clinical trials currently open and recruiting, click here.
MASC Trials has an academic affiliation with Monash University, with a dedicated department supporting our research activities, the MASC Research Centre.
As a registered charity, Melanoma and Skin Cancer Trials Ltd also raises awareness and funds to support research.